Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 5/20 | 0.60 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.41 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.41 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.41 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.41 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.41 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 3/20 | 0.39 |
| ▸ | SRC | P12931 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5660529 | 0.82 | PTGER4 (0.70) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL5119647 | 0.82 | PTGER4 (0.70) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1472722 | 0.82 | PGR (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL12750803 | 0.79 | PTGER4 (0.63) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4821945 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28412652 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL31174405 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL5153575 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28369278 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28446594 | 0.79 | PTGER4 (0.66) | PTGER4PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7915428-B2 | Photorefractive dendron compound, photorefractive dendrimer compound, method of preparing the same, photorefractive device using the same, and method of manufacturing the device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-03-29 | — | — | US | disclosed |
| US-7915428-B2 | Photorefractive dendron compound, photorefractive dendrimer compound, method of preparing the same, photorefractive device using the same, and method of manufacturing the device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-03-29 | — | — | US | disclosed |
| US-20090223627-A1 | PHOTOREFRACTIVE DENDRON COMPOUND, PHOTOREFRACTIVE DENDRIMER COMPOUND, METHOD OF PREREPARING THE SAME, PHOTOREFRACTIVE DEVICE USING THE SAME, AND METHOD OF MANUFACTURING THE DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090223627-A1 | PHOTOREFRACTIVE DENDRON COMPOUND, PHOTOREFRACTIVE DENDRIMER COMPOUND, METHOD OF PREREPARING THE SAME, PHOTOREFRACTIVE DEVICE USING THE SAME, AND METHOD OF MANUFACTURING THE DEVICE | KISS1R, CROCC, DBN1 | PTGER4 2450/4885PSEN1 1642/4885PSEN2 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.